How a Private Equity Firm Left a $2.2 Billion Hole in a Life Insurer

PHL Variable Insurance Co., a former Phoenix Mutual unit bought by Golden Gate Capital’s Nassau, was placed in Connecticut rehabilitation after regulators found a rapidly deteriorating balance sheet that has left policyholders receiving only capped amounts (typically $250,000–$300,000) and at least $400 million of promised benefits effectively withheld; regulators now estimate a roughly $2.2 billion capital shortfall. The failure followed private‑equity driven balance‑sheet engineering—including extensive use of captive reinsurance (about $5.3 billion in reinsurance, $3.5 billion with Concord Re), reduced capital cushions and a roughly 30% allocation to less liquid asset classes such as CLOs and structured notes that have been marked down materially (some positions down a third or more, others over 50%)—and came after multi‑notch rating downgrades. Golden Gate declined to inject fresh capital while Nassau continues to receive fees for services, and the rehabilitator is pursuing recoveries and asset sales; the episode raises litigation, recovery and contagion risks and underscores heightened regulatory scrutiny of private‑equity‑owned life insurers and counterparties.

Analysis

Connecticut regulators placed PHL Variable Insurance Co. into rehabilitation after finding a rapidly deteriorating balance sheet that has capped policyholder payouts at $250,000–$300,000, left at least $400 million of promised benefits effectively withheld and produced an estimated capital shortfall of roughly $2.2 billion. Individual claimants illustrate the impact: a policy that promised $2.0 million yielded only $300,000 to a beneficiary, and a corporate policyholder still pays more than $671,000 per year to maintain coverage projected to pay $18 million.

The collapse followed private‑equity driven balance‑sheet reengineering including extensive captive reinsurance (about $5.3 billion of reinsurance, $3.5 billion with Concord Re), a roughly 30% allocation to less liquid structured products and CLOs that have been marked down materially (some positions down a third, others over 50%), and multi‑notch downgrades (S&P moved the insurer to CCC+ in 2019). A prior capital pledge to keep risk‑adjusted capital above 200% disappeared by 2021 after a $100 million injection and the unit’s move out of Nassau’s stronger entity.

Golden Gate/Nassau declined further capital contributions while PHL continues to pay millions for administration and asset management; the rehabilitator is pursuing recoveries, asset sales and litigation. The episode elevates legal, contagion and regulatory‑oversight risk for private‑equity owned life insurers and counterparties, and creates uncertainty for policyholder recoveries and counterparties tied to Nassau and the captive reinsurers.

Key Decisions for Investors

• Reassess and reduce direct or indirect exposure to private‑equity‑owned life insurers and entities with large captive‑reinsurance stacks or high allocations to illiquid credit until regulators complete rehabilitation and capital recovery estimates are clearer
• For credit and structured‑credit investors, increase monitoring of marks, downgrades and concentration to entities tied to Nassau/Concord Re and consider hedges or wider spreads given materially impaired CLO and structured‑note valuations
• Monitor regulatory filings, court updates and any recovery/litigation outcomes closely for signs of capital infusions or settlements before adding to positions; avoid relying on historical capital pledges that may have been rescinded